Abstract:Objective: Pregnancy requires a complex physiological adaptation of the maternal cardiovascular system, which is disrupted in women with pregnancies complicated by preeclampsia, putting them at higher risk of future cardiovascular events. The measurement of body movements in response to cardiac ejection via ballistocardiogram (BCG) can be used to assess cardiovascular hemodynamics noninvasively in women with preeclampsia. Methods: Using a previously validated, modified weighing scale for assessment of cardiovascular hemodynamics through measurement of BCG and electrocardiogram (ECG) signals, we collected serial measurements throughout pregnancy and postpartum and analyzed data in 30 women with preeclampsia and 23 normotensive controls. Using BCG and ECG signals, we extracted measures of cardiac output, J-wave amplitude × heart rate (J-amp × HR). Mixed-effect models with repeated measures were used to compare J-amp × HRs between groups at different time points in pregnancy and postpartum. Results: In normotensive controls, the J-amp × HR was significantly lower early postpartum (E-PP) compared with the second trimester (T2; p = 0.016) and third trimester (T3; p = 0.001). Women with preeclampsia had a significantly lower J-amp × HR compared with normotensive controls during the first trimester (T1; p = 0.026). In the preeclampsia group, there was a trend toward an increase in J-amp × HR from T1 to T2 and then a drop in J-amp × HR at T3 and further drop at E-PP. Conclusions: We observe cardiac hemodynamic changes consistent with those reported using well-validated tools. In pregnancies complicated by preeclampsia, the maximal force of contraction is lower, suggesting lower cardiac output and a trend in hemodynamics consistent with the hyperdynamic disease model of preeclampsia.

OC17.06: *First trimester cardiac function in women with and without high risk of pre‐eclampsia

OC01.01: *First trimester pre‐eclampsia screening and maternal left ventricular geometry

OC10.07: Fetal advanced neurosonography in the first trimester of pregnancy

OP04.05: Effects of maternal Mediterranean diet on fetal cardiac function in high‐risk pregnancies: the IMPACT BCN trial

EP17.13: CVRI as a quick method to estimate peripheral vascular resistance at 13–16 weeks of gestation in patients at high risk of pre‐eclampsia

OC01.03: Uterine artery vasodilation and its impact on maternal and perinatal outcomes in aspirin‐using pregnant women for preterm pre‐eclampsia prevention

OP15.03: Maternal cardiovascular hemodynamics for the prediction of pre‐eclampsia at 12–16 weeks

EP17.42: Association between mean arterial pressure and uterine artery pulsatility index >95th percentile in first trimester screening in singleton pregnancies

OP16.03: First trimester ultrasound markers for the prediction of adverse pregnancy outcomes in monochorionic diamniotic pregnancies

OC17.01: Effect of antihypertensive therapy on pre‐ and postnatal cardiovascular parameters in hypertensive disorders of pregnancy: a human and animal model

EP17.07: Comparison of different methods of screening for preterm pre‐eclampsia

EP17.66: Prenatal care strategy using clinical factors for pre‐eclampsia risk prediction and prophylaxis indication

EP17.09: Performance of sFlt1 ‐PlGF ratio at 35–36 weeks of gestation in nulliparous women in identifying SGA, pre‐eclampsia and FGR

EP15.02: Fetal cardiac function and Doppler studies in obese pregnant women in comparison with non‐obese women

EP17.15: Evaluation of clinical and biophysical markers as a screening test for late‐onset pre‐eclampsia between 35 and 38 weeks of gestation

OP02.05: AI‐enhanced detection of congenital heart disease suspicion in second trimester ultrasounds by OBGYN and MFM

Use of Ballistocardiography to Monitor Cardiovascular Hemodynamics in Preeclampsia

OP15.08: Mediterranean diet pattern as a protective factor against pre‐eclampsia

EP17.11: Microvascular function assessed by laser speckle contrast imaging in pregnancies complicated by pre‐eclampsia and fetal growth restriction

EP17.63: Association between body mass index and mean uterine artery pulsatility index >95th percentile in first trimester singleton pregnancies screening

Re: Reference ranges of uterine artery pulsatility index from first to third trimester based on serial Doppler measurements: longitudinal cohort study